InvestorsHub Logo
Followers 10
Posts 1040
Boards Moderated 0
Alias Born 07/08/2006

Re: namtae post# 288839

Saturday, 05/05/2018 6:14:35 PM

Saturday, May 05, 2018 6:14:35 PM

Post# of 403446
Nonsense. The FDA is encouraging the the development of ADT's with the eventual replacement of all non-abuse resistant products with ADT's.

Its a shame ADFs will never capture much of a market, they are so deadly forcing non medical users to move to fentanyl & heroin

Then again, Elite doesnt have an ADF and never will with the junk they are fooling investors with, so who cares except the smart shorts



https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm586117.htm

"Transitioning from the current market, dominated by conventional opioids, to one in which most opioids have abuse-deterrent properties, holds significant promise for a meaningful public health benefit."

"In order to support this transition and encourage advancements in this area, today the FDA issued a final guidance to assist industry in their development of generic versions of approved ADF opioids"
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News